SEC Company Response from Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097) (ENTX) — Jun 25, 2018

Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097)
Date: June 25, 2018 · CIK: 0001638097 · Accession: 0000950103-18-007724

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-221472

Date

June 25, 2018

Author

ENTERA BIO LTD.

Form

CORRESP

Company

Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097)

Letter

Division of Corporation Finance Ms. Mary B. Breslin Re: Entera Bio Ltd. Registration Statement on Form F-1 Registration No. 333-221472

Dear Ms. Sarmento and Ms. Breslin,

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:30 p.m. Eastern Daylight Time on June 27, 2018 or as soon thereafter as is practicable. By separate letter, the underwriters of the issuance of the securities being registered join in this request for acceleration.

Please do not hesitate to contact Sophia Hudson of Davis Polk & Wardwell LLP at (212) 450-4762 with any questions or comments with respect to this letter.

[Signature Page Follows]

Sincerely,
ENTERA BIO LTD.

Show Raw Text

CORRESP
1
filename1.htm

    Entera
Bio Ltd.

        Kiryat
        Hadassah

        Minrav
        Building – Fifth Floor

        Jerusalem
        9112002

        Israel

        June 25, 2018

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549-3628

    Attn:
    Ms. Ada D. Sarmento

    Ms. Mary B. Breslin

    Re:
    Entera Bio Ltd.

    Registration Statement on Form F-1

    Registration No. 333-221472

Dear Ms. Sarmento and Ms. Breslin,

Pursuant to Rule 461 under the
Securities Act of 1933, as amended, the undersigned registrant hereby requests that the effective date for the Registration Statement
referred to above be accelerated so that it will be declared effective at 4:30 p.m. Eastern Daylight Time on June 27, 2018 or
as soon thereafter as is practicable. By separate letter, the underwriters of the issuance of the securities being registered
join in this request for acceleration.

Please do not hesitate to contact
Sophia Hudson of Davis Polk & Wardwell LLP at (212) 450-4762 with any questions or comments with respect to this letter.

[Signature
Page Follows]

Sincerely,

    ENTERA BIO LTD.

    By:
    /s/ Dr. Phillip
    Schwartz

    Name:	Dr. Phillip Schwartz

    Title:	Chief Executive Officer

Via EDGAR

CC: Sophia Hudson, Davis Polk
& Wardwell LLP

SecProbe.io